K
307750
vs
AZN
K
307750
AZN
Over the past 12 months, Kukjeon Pharmaceutical Co Ltd has underperformed AZN, delivering a return of +21% compared to the AZN's +23% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
307750
AZN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
K
Intrinsic Value
2 438.03
KRW
Overvaluation 39%
AZN
Intrinsic Value
7 870.67
GBX
Overvaluation 47%
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
K
|
Kukjeon Pharmaceutical Co Ltd
KOSDAQ:307750
|
4 010
KRW
|
|||||
|
AstraZeneca PLC
LSE:AZN
|
14 838
GBX
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
307750, AZN
307750, AZN
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
K
|
Kukjeon Pharmaceutical Co Ltd
Revenue
|
|||||||||||
|
|
AstraZeneca PLC
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
307750, AZN
307750, AZN
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
K
|
Kukjeon Pharmaceutical Co Ltd
KOSDAQ:307750
|
|||||||||
|
|
AstraZeneca PLC
LSE:AZN
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Kukjeon Pharmaceutical Co Ltd
13.6%
AZN
81.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
K
|
Kukjeon Pharmaceutical Co Ltd | ||||
|
|
AstraZeneca PLC | ||||
Operating Margin
Kukjeon Pharmaceutical Co Ltd
-3.3%
AZN
23.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
K
|
Kukjeon Pharmaceutical Co Ltd | ||||
|
|
AstraZeneca PLC | ||||
Net Margin
Kukjeon Pharmaceutical Co Ltd
-2.7%
AZN
17.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
K
|
Kukjeon Pharmaceutical Co Ltd | ||||
|
|
AstraZeneca PLC | ||||
FCF Margin
Kukjeon Pharmaceutical Co Ltd
0.1%
AZN
14.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
K
|
Kukjeon Pharmaceutical Co Ltd | ||||
|
|
AstraZeneca PLC | ||||
ROE
Kukjeon Pharmaceutical Co Ltd
-3.6%
AZN
22.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
K
|
Kukjeon Pharmaceutical Co Ltd | ||||
|
|
AstraZeneca PLC | ||||
ROA
Kukjeon Pharmaceutical Co Ltd
-1.7%
AZN
9.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
K
|
Kukjeon Pharmaceutical Co Ltd | ||||
|
|
AstraZeneca PLC | ||||
ROIC
Kukjeon Pharmaceutical Co Ltd
-2.5%
AZN
13%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
K
|
Kukjeon Pharmaceutical Co Ltd | ||||
|
|
AstraZeneca PLC | ||||
ROCE
Kukjeon Pharmaceutical Co Ltd
-3.5%
AZN
17.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
K
|
Kukjeon Pharmaceutical Co Ltd | ||||
|
|
AstraZeneca PLC | ||||
Solvency Comparison
K
Kukjeon Pharmaceutical Co Ltd
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
307750, AZN
307750, AZN
Performance By Year
307750, AZN
307750, AZN
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 307750 to other stocks
LLY
Eli Lilly and Co
Cheaper
vs Kukjeon Pharmaceutical Co Ltd
JNJ
Johnson & Johnson
Cheaper
vs Kukjeon Pharmaceutical Co Ltd
ROG
Roche Holding AG
Cheaper
vs Kukjeon Pharmaceutical Co Ltd
NOVN
Novartis AG
Cheaper
vs Kukjeon Pharmaceutical Co Ltd
Select Stock to Compare
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
